BibTex RIS Kaynak Göster

Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi

Yıl 2008, Cilt: 39 Sayı: 4, 136 - 143, 20.07.2014

Kaynakça

  • Nosal’ova V, Drabikova K, Zurova-Nedelcevova J, Jancinova V, Okruhlicova L, Nosal R, Sotnikova R. Ischaemia/reperfusion-induced organ injury in low dose streptozotosin diabetes. Neuro Endocrinol Lett 2006; 2: 152-155.
  • Salas A, Panes J, Rosenbloom CL, Elizalde JI, Anderson DC, Granger DN, Pique JM. Differential effects of a nitric oxide donor on reperfusion-induced microvascular dysfunction in diabetic and non-diabetic rats. Diabetologia 1999; 42: 1350-1358.
  • Suzuki O, Matsubara T, Kanashiro M, Nakao 0, Terada J, Nishimura H, Haruta K, Ikeda T, Sakamoto N. Are diabetic hearts more resistant to ischemia/ reperfusion injury? Jpn Circ J 1993; 57: 328-334.
  • Nawata T, Takahashi N, Ooie T, Kaneda K, Saikawa T, Sakata T. Cardioprotection by Streptozotocininduced diabetes and insulin against ischemia/reperfusion injury in rats. J Cardiovasc Pharmacol 2002; 40: 491-500.
  • Korthuis RJ, Smith JK, Carden DL. Hypoxic reperfusion attenuates postischemic microvascular injury. Am J Physiol 1989; 256: 315-319.
  • Pape D, Beuchard J, Guillo P, Allain H, Bellissant E. Hypoxic Contractile Response in ‹solated Rat Thoracic Aorta: Role of Endothelium, Extracellular Calcium and Endothelin. Fundam Clin Pharmacol 1997; 11: 121-126.
  • Gao H, Korthuis RJ, Benoit JN. Effects of Hypoxia/Reoxygenation on Aortic Vasoconstrictor Responsiveness. Free Radic Biol Med 1996; 21: 591600.
  • Lebovitz, H.E. Etiology and Pathogenesis Diabetes Mellitus. Pediatrics Clinics of North America 1984; 31: 521-530.
  • Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-2581.
  • Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of followup. Arch Intern Med 2001; 161: 1717-1723.
  • Tesfamariam P, Halpern W. Endothelium Dependent and Endothelium ‹ndependent Vasodilation in Resistance Arteries from Hypertensive Rats. Hypertension 1988; 11: 440-444.
  • Dohi Y, Thiel M.A. Activation of the Endothelial LArginin Pathway in Pressurized Mesenteric Resistance Arteries: Effect of Age and Hypertension. Hypertension 1990; 15: 170-179.
  • Moncadad S, Higgs E.A. Molecular Mechanism and Therapeutic Strategies Related to NO. Faseb J 1995; 9: 1319-1330.
  • Panza J.A, Brush J.E. Abnormal Endothelium Relaxation in Patients with Essential Hypertension. N Eng J Med 1990; 323: 22-27.
  • Cooke J.P, Andon N.A. Arginine Restores Cholinergic Relaxation of hypercholesterolemic Rabbit Aorta. Circulation 1991; 83: 1057-1062.
  • Lopez-Virella M.F, Virella G. Immune Mechanism of Atherosclerosis in Diabetes Mellitus. Diabetes 1992; 41: 86-91.
  • Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, et al. Ischemia/reperfusion injury. J Surg Res 2002; 105: 248-258.
  • Macleod KM. Effect of Insulin Treatment on Changes in Vascular Reactivity in Chronic Experimental Diabetes. Diabetes 1985; 34: 1160-1167.
  • Piper G.M. Review of Alterations in Endothelial Nitric Oxide Production in Diabetes. Protective Role Arginine on Endothelial Dysfunction. Hypertension 1998; 31: 1047-1060.
  • Karasu Ç, Altan V.M. The Role of Endothelial Cells on Alterations in Vascular Reactivity Induced by Insulin Dependent Diabetes Mellitus: Effect of Insulin Treatment. Gen Pharmacol 1993; 24: 743-755.
  • Karasu Ç, Ozansoy G, Bozkurt O, Erdo¤an G, Ömero¤lu S. Antioxidant and Triglyceride Lowering Effects of Vitamine E Associated with the Prevention of Abnormalities in the Reactivity and Morphology of Aorta from STZ Diabetic Rats. Metabolism 1997; 46: 872-879.
  • Taylor PD, Oon B.B, Thomas C.R, Poston L. Prevention by Insulin Treatment of Endothelial Dysfunction but not Enhanced Noradrenaline ‹nduced Contractility in Mesenteric Resistance Arteries from STZ-Induced Diabetic Rats. Br J Pharmacol 1994; 111: 35-41.
  • Pfaffman M.A, Hilman R, Darby A. Contractilite and Relaxing Activity of Arterial Smooth Muscle from STZ-Diabetic Rats. Res Commun Chem Pathol Pharmacol 1980; 30: 283-299.
  • Ramanadham S, Lynes W.H, Tenner T.E. Alterations in Aortic and Tail Artery Reactivity to Agonists After STZ. Treatment. Can J Physiol Pharmacol 1984; 62: 418-423.
  • Head R.J, Longhurst P.A, Panek R.L, Stitzel R.E. A Contrasting Effect of the Diabetic State up on the Contractile Responses of Aortic Preperation from the Rat and Rabbit. Br J Pharmacol 1987; 91: 275-286.
  • Takiguchi Y, Satoh N, Hashimoto H, Nakashima M. Reserval Effects of Thyroxine on Altered Vascular Reactivity in Diabetic Rats. J Cardiovasc Pharmacol 1989; 13: 520-524.
  • Sikorski B.W, Hodgson W.C, King R.G. Effects of Hemoglobin and N-Nitro-L-Arginine on constrictor and Dilator Responses of Aortic Rings from STZDiabetic Rats. Eur J Pharmacol 1994; 242: 275-282.
  • Owen M.P, Carrier G.O. Alteration in Vascular Smooth Muscle Sensitivity to Vasoconstrictor Agents by STZ-‹nduced Diabetic Diabetes. Proct West Pharmacol Soc 1979; 22: 363-366.
  • Fortes Z.B, Garcia L.C, Scivoletto R.Vascular Reactivitiy in Diabetes Mellitus: Role of Endothelial Cells. Br J Pharmacol 1983; 79: 771-781. 30. Ramos O.L. Diabetes Mellitus and Hypertension: State of Art. Lecture 1988; 11: 114-118.
  • Mulhern M, Docherty J. Effects of Experimentals Diabetes on Responsiveness of Rat Aorta. Br J Pharmacol 1989; 97: 1007-1012.
  • Abiru T, Kamata K. Effects of Diabetes on Vascular Responses of Basillary Artery and Aorta from Rabbits with Alloxan-‹nduced Diabetes. Res. Commun. Chem Pathol Pharmacol 1991; 74: 71-87.
  • Fulton D.J.R, Hodgson W.C. Attenuated Responses to Endothelin–1 KCL and CaCl2 but not Noradrenaline of Aorta from Rats with STZ-induced Diabetes Mellitus. Br J Pharmacol 1991; 104: 928-932.
Yıl 2008, Cilt: 39 Sayı: 4, 136 - 143, 20.07.2014

Kaynakça

  • Nosal’ova V, Drabikova K, Zurova-Nedelcevova J, Jancinova V, Okruhlicova L, Nosal R, Sotnikova R. Ischaemia/reperfusion-induced organ injury in low dose streptozotosin diabetes. Neuro Endocrinol Lett 2006; 2: 152-155.
  • Salas A, Panes J, Rosenbloom CL, Elizalde JI, Anderson DC, Granger DN, Pique JM. Differential effects of a nitric oxide donor on reperfusion-induced microvascular dysfunction in diabetic and non-diabetic rats. Diabetologia 1999; 42: 1350-1358.
  • Suzuki O, Matsubara T, Kanashiro M, Nakao 0, Terada J, Nishimura H, Haruta K, Ikeda T, Sakamoto N. Are diabetic hearts more resistant to ischemia/ reperfusion injury? Jpn Circ J 1993; 57: 328-334.
  • Nawata T, Takahashi N, Ooie T, Kaneda K, Saikawa T, Sakata T. Cardioprotection by Streptozotocininduced diabetes and insulin against ischemia/reperfusion injury in rats. J Cardiovasc Pharmacol 2002; 40: 491-500.
  • Korthuis RJ, Smith JK, Carden DL. Hypoxic reperfusion attenuates postischemic microvascular injury. Am J Physiol 1989; 256: 315-319.
  • Pape D, Beuchard J, Guillo P, Allain H, Bellissant E. Hypoxic Contractile Response in ‹solated Rat Thoracic Aorta: Role of Endothelium, Extracellular Calcium and Endothelin. Fundam Clin Pharmacol 1997; 11: 121-126.
  • Gao H, Korthuis RJ, Benoit JN. Effects of Hypoxia/Reoxygenation on Aortic Vasoconstrictor Responsiveness. Free Radic Biol Med 1996; 21: 591600.
  • Lebovitz, H.E. Etiology and Pathogenesis Diabetes Mellitus. Pediatrics Clinics of North America 1984; 31: 521-530.
  • Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-2581.
  • Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of followup. Arch Intern Med 2001; 161: 1717-1723.
  • Tesfamariam P, Halpern W. Endothelium Dependent and Endothelium ‹ndependent Vasodilation in Resistance Arteries from Hypertensive Rats. Hypertension 1988; 11: 440-444.
  • Dohi Y, Thiel M.A. Activation of the Endothelial LArginin Pathway in Pressurized Mesenteric Resistance Arteries: Effect of Age and Hypertension. Hypertension 1990; 15: 170-179.
  • Moncadad S, Higgs E.A. Molecular Mechanism and Therapeutic Strategies Related to NO. Faseb J 1995; 9: 1319-1330.
  • Panza J.A, Brush J.E. Abnormal Endothelium Relaxation in Patients with Essential Hypertension. N Eng J Med 1990; 323: 22-27.
  • Cooke J.P, Andon N.A. Arginine Restores Cholinergic Relaxation of hypercholesterolemic Rabbit Aorta. Circulation 1991; 83: 1057-1062.
  • Lopez-Virella M.F, Virella G. Immune Mechanism of Atherosclerosis in Diabetes Mellitus. Diabetes 1992; 41: 86-91.
  • Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, et al. Ischemia/reperfusion injury. J Surg Res 2002; 105: 248-258.
  • Macleod KM. Effect of Insulin Treatment on Changes in Vascular Reactivity in Chronic Experimental Diabetes. Diabetes 1985; 34: 1160-1167.
  • Piper G.M. Review of Alterations in Endothelial Nitric Oxide Production in Diabetes. Protective Role Arginine on Endothelial Dysfunction. Hypertension 1998; 31: 1047-1060.
  • Karasu Ç, Altan V.M. The Role of Endothelial Cells on Alterations in Vascular Reactivity Induced by Insulin Dependent Diabetes Mellitus: Effect of Insulin Treatment. Gen Pharmacol 1993; 24: 743-755.
  • Karasu Ç, Ozansoy G, Bozkurt O, Erdo¤an G, Ömero¤lu S. Antioxidant and Triglyceride Lowering Effects of Vitamine E Associated with the Prevention of Abnormalities in the Reactivity and Morphology of Aorta from STZ Diabetic Rats. Metabolism 1997; 46: 872-879.
  • Taylor PD, Oon B.B, Thomas C.R, Poston L. Prevention by Insulin Treatment of Endothelial Dysfunction but not Enhanced Noradrenaline ‹nduced Contractility in Mesenteric Resistance Arteries from STZ-Induced Diabetic Rats. Br J Pharmacol 1994; 111: 35-41.
  • Pfaffman M.A, Hilman R, Darby A. Contractilite and Relaxing Activity of Arterial Smooth Muscle from STZ-Diabetic Rats. Res Commun Chem Pathol Pharmacol 1980; 30: 283-299.
  • Ramanadham S, Lynes W.H, Tenner T.E. Alterations in Aortic and Tail Artery Reactivity to Agonists After STZ. Treatment. Can J Physiol Pharmacol 1984; 62: 418-423.
  • Head R.J, Longhurst P.A, Panek R.L, Stitzel R.E. A Contrasting Effect of the Diabetic State up on the Contractile Responses of Aortic Preperation from the Rat and Rabbit. Br J Pharmacol 1987; 91: 275-286.
  • Takiguchi Y, Satoh N, Hashimoto H, Nakashima M. Reserval Effects of Thyroxine on Altered Vascular Reactivity in Diabetic Rats. J Cardiovasc Pharmacol 1989; 13: 520-524.
  • Sikorski B.W, Hodgson W.C, King R.G. Effects of Hemoglobin and N-Nitro-L-Arginine on constrictor and Dilator Responses of Aortic Rings from STZDiabetic Rats. Eur J Pharmacol 1994; 242: 275-282.
  • Owen M.P, Carrier G.O. Alteration in Vascular Smooth Muscle Sensitivity to Vasoconstrictor Agents by STZ-‹nduced Diabetic Diabetes. Proct West Pharmacol Soc 1979; 22: 363-366.
  • Fortes Z.B, Garcia L.C, Scivoletto R.Vascular Reactivitiy in Diabetes Mellitus: Role of Endothelial Cells. Br J Pharmacol 1983; 79: 771-781. 30. Ramos O.L. Diabetes Mellitus and Hypertension: State of Art. Lecture 1988; 11: 114-118.
  • Mulhern M, Docherty J. Effects of Experimentals Diabetes on Responsiveness of Rat Aorta. Br J Pharmacol 1989; 97: 1007-1012.
  • Abiru T, Kamata K. Effects of Diabetes on Vascular Responses of Basillary Artery and Aorta from Rabbits with Alloxan-‹nduced Diabetes. Res. Commun. Chem Pathol Pharmacol 1991; 74: 71-87.
  • Fulton D.J.R, Hodgson W.C. Attenuated Responses to Endothelin–1 KCL and CaCl2 but not Noradrenaline of Aorta from Rats with STZ-induced Diabetes Mellitus. Br J Pharmacol 1991; 104: 928-932.
Toplam 32 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştırmalar
Yazarlar

Samet Yalçın Bu kişi benim

Bülent Yalçın Bu kişi benim

Yayımlanma Tarihi 20 Temmuz 2014
Yayımlandığı Sayı Yıl 2008 Cilt: 39 Sayı: 4

Kaynak Göster

APA Yalçın, S., & Yalçın, B. (2014). Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi. Cerrahpaşa Tıp Dergisi, 39(4), 136-143.
AMA Yalçın S, Yalçın B. Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi. Cerrahpaşa Tıp Dergisi. Temmuz 2014;39(4):136-143.
Chicago Yalçın, Samet, ve Bülent Yalçın. “Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi”. Cerrahpaşa Tıp Dergisi 39, sy. 4 (Temmuz 2014): 136-43.
EndNote Yalçın S, Yalçın B (01 Temmuz 2014) Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi. Cerrahpaşa Tıp Dergisi 39 4 136–143.
IEEE S. Yalçın ve B. Yalçın, “Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi”, Cerrahpaşa Tıp Dergisi, c. 39, sy. 4, ss. 136–143, 2014.
ISNAD Yalçın, Samet - Yalçın, Bülent. “Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi”. Cerrahpaşa Tıp Dergisi 39/4 (Temmuz 2014), 136-143.
JAMA Yalçın S, Yalçın B. Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi. Cerrahpaşa Tıp Dergisi. 2014;39:136–143.
MLA Yalçın, Samet ve Bülent Yalçın. “Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi”. Cerrahpaşa Tıp Dergisi, c. 39, sy. 4, 2014, ss. 136-43.
Vancouver Yalçın S, Yalçın B. Diyabetes Mellitusun Vasküler Cevaba Olan Etkisinin İskemi Reperfüzyon Modelinde İncelenmesi. Cerrahpaşa Tıp Dergisi. 2014;39(4):136-43.